- Home
- INBS vs MGRX Comparison
INBS vs MGRX Comparison
Compare INBS & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBS
- MGRX
- Stock Information
- Founded
- INBS 2016
- MGRX 2021
- Country
- INBS United States
- MGRX United States
- Employees
- INBS N/A
- MGRX N/A
- Industry
- INBS Medical Specialities
- MGRX Computer Software: Prepackaged Software
- Sector
- INBS Health Care
- MGRX Technology
- Exchange
- INBS Nasdaq
- MGRX Nasdaq
- Market Cap
- INBS 6.3M
- MGRX 6.3M
- IPO Year
- INBS N/A
- MGRX 2023
- Fundamental
- Price
- INBS $1.30
- MGRX $2.48
- Analyst Decision
- INBS
- MGRX
- Analyst Count
- INBS 0
- MGRX 0
- Target Price
- INBS N/A
- MGRX N/A
- AVG Volume (30 Days)
- INBS 132.7K
- MGRX 100.9K
- Earning Date
- INBS 02-07-2025
- MGRX 11-14-2024
- Dividend Yield
- INBS N/A
- MGRX N/A
- EPS Growth
- INBS N/A
- MGRX N/A
- EPS
- INBS N/A
- MGRX N/A
- Revenue
- INBS $3,187,974.00
- MGRX $755,000.00
- Revenue This Year
- INBS $280.88
- MGRX N/A
- Revenue Next Year
- INBS $126.26
- MGRX N/A
- P/E Ratio
- INBS N/A
- MGRX N/A
- Revenue Growth
- INBS 55.29
- MGRX 52.20
- 52 Week Low
- INBS $1.00
- MGRX $2.10
- 52 Week High
- INBS $11.70
- MGRX $16.80
- Technical
- Relative Strength Index (RSI)
- INBS 36.48
- MGRX 47.52
- Support Level
- INBS $1.20
- MGRX $2.41
- Resistance Level
- INBS $1.69
- MGRX $2.63
- Average True Range (ATR)
- INBS 0.12
- MGRX 0.15
- MACD
- INBS -0.04
- MGRX 0.00
- Stochastic Oscillator
- INBS 19.61
- MGRX 59.46
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.